DMAAR
Drugs Made In America Acquisition Corp.
Key Financials
Net Income
$-279845
N/A
EPS (Diluted)
$-0.03
N/A
Total Liabilities
$795669.00
N/A
Operating Income
$-726547
N/A
Shareholders' Equity
$-244845.00
N/A
Operating Cash Flow
$-172265.00
N/A
Total Assets
$550824.00
N/A
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | DMAAR |
| Company Name | Drugs Made In America Acquisition Corp. |
| CIK | 2028614 |
| SIC Code | 6770 |
| SIC Description | Blank Checks |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 954-870-3104 |